PDP-EA

CAS No. 861891-72-7

PDP-EA( —— )

Catalog No. M27912 CAS No. 861891-72-7

PDP-EA is an activator of fatty acid amide hydrolase(FAAH) and enhances the amidohydrolase activity of FAAH.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 65 Get Quote
10MG 110 Get Quote
25MG 177 Get Quote
50MG 267 Get Quote
100MG 408 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PDP-EA
  • Note
    Research use only, not for human use.
  • Brief Description
    PDP-EA is an activator of fatty acid amide hydrolase(FAAH) and enhances the amidohydrolase activity of FAAH.
  • Description
    PDP-EA is an activator of fatty acid amide hydrolase(FAAH) and enhances the amidohydrolase activity of FAAH.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    FAAH
  • Recptor
    IGFBP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    861891-72-7
  • Formula Weight
    405.623
  • Molecular Formula
    C25H43NO3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (123.27 mM)
  • SMILES
    CCCCCCCCCCCCCCCc1cccc(OCC(=O)NCCO)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Rinker TE, et al. Microparticle-mediated sequestration of cell-secreted proteins to modulate chondrocytic differentiation. Acta Biomater. 2017 Dec 30. pii: S1742-7061(17)30804-8.
molnova catalog
related products
  • FAAH inhibitor 1

    FAAH inhibitor 1 is an effective FAAH inhibitor with an IC50 of 18 nM.

  • Palmitoylisopropylam...

    Palmitoylisopropylamide is a selective FAAH inhibitor that inhibits [H]-AEA uptake and cell proliferation at low concentrations.

  • CB2R/FAAH?modulator-...

    CB2R/FAAH?modulator-1, a cannabinoid type 2 receptor (CB2R) agonist, is also a fatty acid amide hydrolase (FAAH) inhibitor (IC50=4 μM) that reduces the production of pro-inflammatory and anti-inflammatory cytokines and is commonly used in inflammation studies.